CClinicalTrials.gg
CompletedNCT07736209Updated Jul 30, 2026

Effects of Heavy Back-Squat PAPE on Jump and Repeated Sprint Performance in Trained Soccer Players

An interventional study of Heavy Back-Squat PAPE Protocol and Standardized Warm-Up Control Condition in Post-activation Performance Enhancement and Repeated Sprint Performance in Trained Soccer Players, sponsored by Istanbul University - Cerrahpasa. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 20 Years to 23 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-30.

Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Dec 2025, registered Jul 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
20 Years to 23 Years
Sex
Male
01

Study summary

This study examined whether performing heavy back squats before exercise affects jumping ability and repeated sprint performance in trained soccer players. Twenty male university soccer players completed two testing sessions in a randomized crossover design. In one session, participants performed a standardized warm-up only. In the other session, they performed the same warm-up followed by three sets of three back-squat repetitions at 90% of their one-repetition maximum. The two sessions were separated by one week. After each condition, participants completed a countermovement jump test and an 18 × 40-meter repeated sprint test. The study aimed to determine whether the heavy back-squat activity improves early explosive performance and whether it increases fatigue during prolonged repeated sprint exercise.

02

Conditions studied

  • Post-activation Performance Enhancement and Repeated Sprint Performance in Trained Soccer Players
03

In context

Lead sponsor

Istanbul University - Cerrahpasa is the lead sponsor of 680 studies on the registry; 208 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 23 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male soccer players aged 20-23 years.
  • Currently competing in the top division of a university soccer league.
  • A minimum of three years of regular soccer training experience.
  • Free from long-term musculoskeletal injury during the previous six months.
  • Willing and able to complete all familiarization, strength-testing, and experimental sessions.
  • Provision of written informed consent.

Exclusion criteria

Exclusion Criteria:

  • A musculoskeletal injury resulting in an absence from training or competition for 21 days or longer during the previous six months.
  • Use of medications or nutritional or ergogenic supplements that could affect exercise performance.
  • Any health or physical condition preventing safe participation in heavy back-squat, countermovement jump, or repeated sprint testing.
  • Failure to complete both experimental conditions.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Control-PAPE Sequence

    Participants first completed the Control condition, consisting of a standardized warm-up without an additional conditioning activity. After a one-week washout period, participants completed the PAPE condition, consisting of the same standardized warm-up followed by three sets of three back-squat repetitions at 90% of one-repetition maximum, with 3 minutes of passive recovery between sets. Countermovement jump and repeated sprint performance were assessed after each condition.

    Behavioral: Heavy Back-Squat PAPE Protocol · Behavioral: Standardized Warm-Up Control Condition

  • Experimental
    PAPE-Control Sequence

    Participants first completed the PAPE condition, consisting of a standardized warm-up followed by three sets of three back-squat repetitions at 90% of one-repetition maximum, with 3 minutes of passive recovery between sets. After a one-week washout period, participants completed the Control condition, consisting of the same standardized warm-up without an additional conditioning activity. Countermovement jump and repeated sprint performance were assessed after each condition.

    Behavioral: Heavy Back-Squat PAPE Protocol · Behavioral: Standardized Warm-Up Control Condition

Interventions

  • BehavioralHeavy Back-Squat PAPE Protocol

    Participants completed a standardized warm-up followed by a heavy back-squat conditioning activity consisting of three sets of three repetitions at 90% of one-repetition maximum. Three minutes of passive recovery were provided between sets. Countermovement jump performance was assessed approximately 4.5-5 minutes after the final squat set, immediately before the repeated sprint test.

  • BehavioralStandardized Warm-Up Control Condition

    Participants completed a standardized warm-up consisting of 5 minutes of jogging, followed by 10 bodyweight squats, 10 lunges, and 10 lateral shuffles. No additional conditioning activity was performed. After approximately 5 minutes of passive recovery, countermovement jump performance was assessed immediately before the repeated sprint test.

06

What researchers measure

Primary outcomes

  1. Repeated Sprint Performance Decrement

    Percentage decline in repeated sprint performance calculated from sprint times recorded during an 18 × 40-meter shuttle sprint test. The protocol consisted of three sets of six 40-meter shuttle sprints, with 20 seconds of passive recovery between sprints and 4 minutes of passive recovery between sets. Lower percentage values indicate better maintenance of sprint performance and less fatigue.

    Time frame: During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.

  2. Countermovement Jump Height

    Maximum countermovement jump height measured in centimeters using the Optojump Next optical measurement system. Participants performed three maximal countermovement jump trials with their hands positioned on their hips and 60 seconds of passive recovery between trials. The highest jump height was used for analysis. Higher values indicate better jump performance.

    Time frame: At approximately 5 minutes after the assigned condition, within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.

Secondary outcomes

  1. Mean Repeated Sprint Time

    Mean sprint time, measured in seconds, calculated across all 18 repetitions of the 40-meter shuttle sprint test. Sprint times were recorded using a photocell timing system. Lower values indicate better repeated sprint performance.

    Time frame: During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.

  2. Best Sprint Time

    The fastest sprint time, measured in seconds, recorded among the 18 repetitions of the 40-meter shuttle sprint test using a photocell timing system. Lower values indicate better sprint performance.

    Time frame: During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.

  3. Worst Sprint Time

    The slowest sprint time, measured in seconds, recorded among the 18 repetitions of the 40-meter shuttle sprint test using a photocell timing system. Lower values indicate better sprint performance.

    Time frame: During the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period.

  4. Sprint Time Across Individual Repetitions

    Sprint time, measured in seconds, for each of the 18 individual 40-meter shuttle sprint repetitions. Sprint-by-sprint values were used to evaluate changes in performance during the early repetitions (sprints 1-3), middle repetitions (sprints 4-8), and later repetitions (sprints 9-18). Lower values indicate faster sprint performance.

    Time frame: During each repetition of the 18 × 40-meter repeated sprint test, which lasted approximately 15 minutes and was completed within each of two experimental sessions lasting approximately 25-35 minutes; the sessions were separated by a 1-week washout period

07

Study locations

1 site
  • Istanbul University Cerrahpaşa
    Istanbul, Istanbul 34320, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07736209
Lead sponsor
Istanbul University - Cerrahpasa
Responsible party
Abdullah Demirli (Istanbul University-Cerrahpaşa, Istanbul University - Cerrahpasa) — Principal investigator
First posted
Jul 30, 2026
Start date
Dec 20, 2025
Primary completion
Feb 15, 2026
Completion
Feb 15, 2026
Last update
Jul 30, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion